Neurocognitive Function
20
5
5
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.0%
1 terminated out of 20 trials
90.0%
+3.5% vs benchmark
10%
2 trials in Phase 3/4
11%
1 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (20)
UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
Brain Connectivity Changes in Glioma Patients During Treatment
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)
taVNS + CCT for Neurocognitive Rehab
Personalized Performance Optimization Platform
Mindfulness-Based Peak Performance, Endurance Performance Under Pressure, Performance-relevant Mental Attributes
Target-Controlled Infusion and Postoperative Neurocognitive Outcomes in Geriatric Patients
Neuromusculoskeletal Alterations After ACL Injury
Neuro-Athletic Training in Football
3-Dimensional Evaluation of Body Perception
Mindfulness Training, Mental Fatigue, Endurance Performance and Neurocognitive Functions
Exercise and Neurocognition in Adults Relative to ApoE Genotype
Acute Exercise Type and Cognitive Function: An Event-related Potential Study
Neurocognitive Function After Regional and General Anesthesia (245_14 B)
Neurocognitive Function After Therapy of OSAS
The Effects of 12 Weeks Supplementation With a B-vitamin and Herbal Supplement on Neurocognitive Function and Mood
Memory Preservation of Hippocampal Avoidance Whole Brain Radiotherapy
Anticoagulation in AF Ablation and Effects on Neurocognitive Function
Tardive Dyskinesia and Cognitive Function